NMI 8739
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


NMI 8739
Description:
NMI 8739 is a dopamine D2 autoreceptor agonist, which is an amine conjugate of the DHA carrier and the neurotransmitter dopamine.UNSPSC:
12352005Hazard Statement:
H225, H319Target:
Dopamine ReceptorType:
Reference compoundRelated Pathways:
GPCR/G Protein; Neuronal SignalingApplications:
Neuroscience-NeuromodulationField of Research:
Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/Doprexin.htmlPurity:
99.91Solubility:
DMSO : 65 mg/mL (ultrasonic) |Ethanol : 100 mg/mL (ultrasonic)Smiles:
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(NCCC1=CC=C(O)C(O)=C1)=OMolecular Formula:
C30H41NO3Molecular Weight:
463.65Precautions:
H225, H319References & Citations:
[1]Gill Higgins, New drugs signal rapid growth of anti-obesity drug market. RESEARCH & DEVELOPMENT. 2 Nov 11K16 No. 1061|[2]Shashoua VE, et al. N-docosahexaenoyl, 3 hydroxytyramine: a dopaminergic compound that penetrates the blood-brain barrier and suppresses appetite. Life Sci. 1996;58 (16) :1347-57.|[3]Wang Y, et al. N-Docosahexaenoyl Dopamine, an Endocannabinoid-like Conjugate of Dopamine and the n-3 Fatty Acid Docosahexaenoic Acid, Attenuates Lipopolysaccharide-Induced Activation of Microglia and Macrophages via COX-2. ACS Chem Neurosci. 2017 Mar 15;8 (3) :548-557.Shipping Conditions:
Blue IceStorage Conditions:
-20°C (Powder, protect from light)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
D2 ReceptorCAS Number:
[129024-87-9]
